Results 171 to 180 of about 57,449 (202)

Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper

Science Translational Medicine, 2022
Andrew S Huhn, Patrick Finan, Alexis S Hammond   +2 more
exaly  

Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder

American Journal of Psychiatry, 2020
Hillary Samples, Stephen Crystal, Mark Olfson   +2 more
exaly  

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Lancet, The, 2018
Joshua D Lee, Edward V Nunes, Marc Fishman   +2 more
exaly  

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2019
Mark K Greenwald, Vijay R Nadipelli, Christian Heidbreder   +2 more
exaly  

Perioperative Buprenorphine

Journal of PeriAnesthesia Nursing, 2019
openaire   +2 more sources

Buprenorphine

Reactions Weekly, 2004
openaire   +2 more sources

The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review

American Journal of Psychiatry, 2017
Kathleen M Carroll
exaly  

Buprenorphine

Reactions Weekly, 2015
openaire   +2 more sources

Buprenorphine

Journal of Exotic Pet Medicine, 2019
openaire   +2 more sources

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

Lancet, The, 2003
, Mary Jeanne Kreek, Markus Heilig
exaly